The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Workforce
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Kawasaki Disease Spread May be Linked to Wind

Kawasaki Disease Spread May be Linked to Wind

October 1, 2014 • By Richard Quinn

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Blowing in the wind

A new study links the spread of Kawasaki disease (KD) in the Far East and the Western U.S. to winds from farmland in northeast China. And the lead author says that rheumatologists studying other rheumatic diseases may want to view the wind as a potential factor in their spread.

You Might Also Like
  • 2013 ACR/ARHP Annual Meeting: Diagnostic,Treatment Approaches Evolve for Kawasaki Disease
  • Gene Expression Signature Useful for Diagnosing Kawasaki Disease
  • Exploring Kawasaki Disease
Explore This Issue
October 2014
Also By This Author
  • Sequester Affects Rheumatologists on Two Fronts—Medicare Reimbursement and Research Funding

The Basics

KD is an acute febrile illness of unknown etiology that primarily affects children younger than 5 years old.1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

KD “is characterized by fever, rash, swelling of the hands and feet, irritation and redness of the whites of the eyes, swollen lymph glands in the neck, and irritation and inflammation of the mouth, lips, and throat. Serious complications include coronary artery dilatations and aneurysms. The standard treatment with intravenous immunoglobulin and aspirin substantially decreases the development of these coronary artery abnormalities.”

KD occurs worldwide, with the highest incidence in Japan. It most often affects boys and younger children.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Cultivated fields in northeast China.
Pictured: Cultivated fields in northeast China.

The Study

The new study offers “a different way to look at these sorts of diseases,” says author Xavier Rodó, PhD, an ecologist and climate scientist at the Catalan Institute of Climate Sciences (IC3) in Barcelona, Spain.

Dr. Rodó’s study, “Tropospheric winds from northeastern China carry the etiologic agent of Kawasaki disease from its source to Japan,” was published online this spring by the Proceedings of the National Academy of Sciences.2 It reported that evidence indicates the “densely cultivated region of northeastern China acts as a source for the wind-borne agent” of KD.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

“We’re not saying that the KD agent worldwide comes from this region, but that this is the case for Japan and the U.S.,” Dr. Rodó says.

KD is the leading cause of acquired heart disease in children worldwide and causes inflammation, conjunctivitis and other maladies. But little is known of the disease’s background. It primarily affects children younger than age 5 and was first reported in 1967 in Japan. The first reported cases outside of Japan were in Hawaii in 1976, according to the Centers for Disease Control and Prevention.1

Highlighting the importance to rheumatologists, a panel discussion at the 2013 ACR/ARHP Annual Meeting, titled, Kawasaki Disease: Putting Out the Fire, noted the need for early detection of the disease. One of the experts said it’s estimated that one in 1,600 adults in the U.S. will have had KD by 2030.3

Dr. Rodó notes that it’s important for rheumatologists and other physicians to realize the study does not identify KD’s etiologic agent. It also does not confirm whether the agent is a fungus, toxin or another kind of environmental particle.

Pages: 1 2 | Single Page

Filed Under: Career Development, Conditions, Education & Training, Professional Topics, Systemic Inflammatory Syndromes Tagged With: ACR/ARHP Annual Meeting, China, Japan, Kawasaki disease, microbe, Quinn, rheumatologistIssue: October 2014

You Might Also Like:
  • 2013 ACR/ARHP Annual Meeting: Diagnostic,Treatment Approaches Evolve for Kawasaki Disease
  • Gene Expression Signature Useful for Diagnosing Kawasaki Disease
  • Exploring Kawasaki Disease
  • The Legacy of Amyloid: Infiltration Linked to Dementia, Rheumatic Disease

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.